The latest IP developments in Brazil and Mexico

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The latest IP developments in Brazil and Mexico

Rio 168

Our latest supplements, focusing on Brazil and Mexico, are now available to read online for free

Managing IP has just published our latest supplements, focusing on Brazil and Mexico.

The Brazil articles discuss life sciences and enforcement.

New Brazilian regulation encourages life sciences innovation A new decree regulates Brazil’s Biodiversity Law. Kene Gallois and Danielle Altomari of Daniel Advogados explain why this can represent friendly prospects for innovative life sciences companies Enforcement and licensing on the rise in Brazil José Carlos Vaz e Dias of Vaz e Dias Advogados & Associados reports on the latest developments to improve the Brazilian IP system

The Mexico articles discuss the Trans-Pacific Partnership, the new opposition system, online marketplaces, patent eligible subject matter and IT as evidence to prove trade mark use.

Mexico and the TPP Jorge Vega, Eduardo Castañeda and Guillermo González of Basham Ringe and Correa explain how the Trans-Pacific Partnership would affect Mexico’s IP system Madrid System and Mexico’s opposition system Laura Collada and Ariadna Galvez of Dumont Bergman Bider & Co discuss Mexico’s experience of the Madrid System since 2013 and point out some flaws in its new opposition system Why online marketplaces should implement IP protection programmes Fernanda Díaz and Víctor Ramírez of Olivares discuss the role and responsibilities of online intermediaries in connection with IP rights in Mexico Mexican law and practice related to patent eligible subject matter Héctor Chagoya and Claudia Campos of Becerril Coca & Becerril discuss the features of the Mexican patent system under a new environment for human creativity recognition, and analyse statutory provisions given the scarcity of administrative or judiciary precedents available for interpreting Mexican law Information technology and proving trade mark use Enrique Romano Barragán of Goodrich discusses the importance of information technology as evidence to prove trade mark use in cancellation actions on grounds of lack of use according to Mexican law

Managing IP has also this year published supplements on Asia Pacific, Canada, Europe, India, Americas, China and Turkey. You can view them all here.

more from across site and SHARED ros bottom lb

More from across our site

Find out which firms secured the most nominations for Managing IP’s Asia-Pacific Awards 2025, ahead of the winners being revealed on November 6
Raluca Vasilescu joins our ‘Five minutes with’ series to discuss patent mining and watercolour painting
Jan Phillip Rektorschek, founding partner at Pentarc in Germany, explains why the firm broke away from Taylor Wessing and discusses its plans for staying competitive
Royal Mail Group wins copyright and database right infringement case, in a dispute that can be linked to the history of postcodes in the UK
Managing partner Mark O’Donnell explains why people are at the centre of the Australian outfit’s investment focus and how being independent benefits the firm
IP is becoming one of the most significant drivers of major deals, and law firms are altering their practices to reflect the change
In the second in a new podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IPause, a network set up to support those experiencing (peri)menopause
Firms are adapting litigation strategy as Brazil’s unique legal system and technical expertise have made preliminary injunctions a key tool in global patent disputes
A ruling on confidentiality by the the England and Wales Court of Appeal and an intervention from the US government in the InterDigital v Disney litigation were also among top talking points
Moore & Van Allen hires former Teva counsel Larry Rickles to help expand the firm’s life sciences capabilities
Gift this article